1.97
price up icon1.03%   0.02
after-market Dopo l'orario di chiusura: 1.96 -0.01 -0.51%
loading
Precedente Chiudi:
$1.95
Aprire:
$1.99
Volume 24 ore:
2.27M
Relative Volume:
1.58
Capitalizzazione di mercato:
$140.96M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+28.76%
1M Prestazione:
-28.62%
6M Prestazione:
+57.60%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$1.95
$2.3791
Intervallo di 1 settimana:
Value
$1.47
$2.3791
Portata 52W:
Value
$0.5506
$6.19

Citius Oncology Inc Stock (CTOR) Company Profile

Name
Nome
Citius Oncology Inc
Name
Telefono
(908) 967-6677
Name
Indirizzo
11 COMMERCE DRIVE, CRANFORD
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
CTOR's Discussions on Twitter

Confronta CTOR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
CTOR
Citius Oncology Inc
1.97 152.82M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
152.12 68.04B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.48 46.30B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.88 44.25B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.54 18.73B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
304.50 13.82B 2.99B 1.21B 1.13B 25.06

Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-27 Iniziato Maxim Group Buy

Citius Oncology Inc Borsa (CTOR) Ultime notizie

pulisher
Jul 25, 2025

Is Citius Oncology Inc. a good long term investmentExceptional trading performance - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

Citius Oncology Announces Closing of $9.0 Million Public Offering - StreetInsider

Jul 24, 2025
pulisher
Jul 23, 2025

Citius Oncology Inc. Stock Analysis and ForecastMarket-leading capital gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Citius Oncology Inc. stock priceConsistently exceptional gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Citius Oncology Inc. stockFree Wealth Management Insights - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

Citius Oncology shares rise 1.31% after-hours after closing a $9.0 million public offering. - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Should I buy Citius Oncology Inc. stock before earningsShort Term High Return Strategy - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Citius Oncology Completes $9M Public Offering - TipRanks

Jul 18, 2025
pulisher
Jul 17, 2025

Citius Oncology launches $15M equity and warrant offering; shares down - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology closes $9 million public offering to support LYMPHIR - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology closes $9 million public offering to support LYMPHIR By Investing.com - Investing.com Nigeria

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology Raises $9M in Public Offering for LYMPHIR Commercialization - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology Announces Closing Of $9.0 Million Public Offering - Barchart.com

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology Announces Pricing Of $9M "Reasonable Best-Efforts" Public Offering Of 6,818,182 Shares Of Common Stock And Warrants To Purchase Shares Of Common Stock At A Public Offering Price Of $1.32 Per Share - 富途牛牛

Jul 17, 2025
pulisher
Jul 16, 2025

Citius Pharmaceuticals shares fall 1.34% after-hours following Citius Oncology's public offering. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology’s Chances: Time to Invest? - StocksToTrade

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology Announces Pricing of $9.0 Million Public Offering - Finansavisen

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology Soars 35.06% on Distribution Deal - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology Soars 12.34% on Expanded Lymphir Distribution - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

Citius Oncology stock rises after expanding LYMPHIR distribution network - Investing.com

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Citius Oncology Inc. stock price move sharplySecure Your Capital Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Citius Oncology Inc. stock attracts strong analyst attentionEarly Breakout Tracker - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology Shares Climb Following Expansion of LYMPHIR Distribution Network - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology (CTOR): Is LYMPHIR's Launch Priced for Success? - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology: Is A Lymphir Launch Coming Too Late? - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Pharmaceuticals (CTXR) Surges on New Distribution Deal - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology stock rises after expanding LYMPHIR distribution network By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

How Citius Oncology Inc. stock performs during market volatilityLow Risk Entry Points - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology Expands Lymphir Distribution With Cencora - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Cencora distribution deal boosts Citius shares - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology expands distribution network for LYMPHIR with Cencora - Investing.com Australia

Jul 15, 2025
pulisher
Jul 15, 2025

Citius stock gains on Cencora distribution deal (CTXR:NASDAQ) - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology expands distribution network for LYMPHIR with Cencora By Investing.com - Investing.com Nigeria

Jul 15, 2025

Citius Oncology Inc Azioni (CTOR) Dati Finanziari

Non sono disponibili dati finanziari per Citius Oncology Inc (CTOR). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$72.93
price up icon 2.82%
$14.92
price up icon 1.57%
$9.41
price up icon 0.64%
drug_manufacturers_specialty_generic RDY
$14.67
price down icon 0.27%
$132.14
price up icon 0.38%
$304.50
price down icon 0.62%
Capitalizzazione:     |  Volume (24 ore):